IBRX
#1043
ImmunityBio, Inc. - Common Stock
7.5 2 USD
-2.59%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.59%
Monthly Change
+7.58%
6 month change
+214.64%
Year Change
+184.85%
Previous Close
7.7 2
Open
7.5 2
Low
7.5 2
High
7.5 2
Volume
155
Financials
- Market Capitalization 7.88 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.02
Price to sales ratio
51.72